Bottom line
What is FHCBX's expense ratio?
FHCBX's expense ratio is 0.4%, or about $40 a year on every $10,000 invested. That is cheaper than 92% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.15% 12b-1 marketing fee.
Updated Oct 28, 2026
FHCBX fee table
| Net expense ratio | 0.4% |
|---|---|
| Gross expense ratio | 0.61% |
| Management fee | 0.25% |
| 12b-1 (distribution) fee | 0.15% |
| Other expenses | 0.21% |
| Fee waiver / reimbursement | -0.21% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What FHCBX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| FHCBX | $62 | $195 | $340 | $762 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.4% expense ratio costs roughly $23,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).